TWI256393B - 3-Phenyl-3,7-diazabicyclo [3,3,1] nonane compounds and process for their preparation and medicaments containing these compounds - Google Patents

3-Phenyl-3,7-diazabicyclo [3,3,1] nonane compounds and process for their preparation and medicaments containing these compounds

Info

Publication number
TWI256393B
TWI256393B TW091109628A TW91109628A TWI256393B TW I256393 B TWI256393 B TW I256393B TW 091109628 A TW091109628 A TW 091109628A TW 91109628 A TW91109628 A TW 91109628A TW I256393 B TWI256393 B TW I256393B
Authority
TW
Taiwan
Prior art keywords
compounds
carbon atoms
phenyl
diazabicyclo
preparation
Prior art date
Application number
TW091109628A
Other languages
English (en)
Inventor
Uwe Schon
Josef Messinger
Reinhard Bruckner
Dieter Ziegler
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of TWI256393B publication Critical patent/TWI256393B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW091109628A 2001-06-28 2002-05-08 3-Phenyl-3,7-diazabicyclo [3,3,1] nonane compounds and process for their preparation and medicaments containing these compounds TWI256393B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10131217A DE10131217A1 (de) 2001-06-28 2001-06-28 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
TWI256393B true TWI256393B (en) 2006-06-11

Family

ID=7689787

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091109628A TWI256393B (en) 2001-06-28 2002-05-08 3-Phenyl-3,7-diazabicyclo [3,3,1] nonane compounds and process for their preparation and medicaments containing these compounds

Country Status (30)

Country Link
US (1) US6602880B2 (zh)
EP (1) EP1270576B1 (zh)
JP (1) JP4223237B2 (zh)
KR (1) KR20030002304A (zh)
CN (1) CN1303082C (zh)
AR (1) AR033772A1 (zh)
AT (1) ATE276254T1 (zh)
AU (1) AU781333B2 (zh)
BR (1) BR0202419A (zh)
CA (1) CA2391915C (zh)
CZ (1) CZ296878B6 (zh)
DE (2) DE10131217A1 (zh)
DK (1) DK1270576T3 (zh)
DZ (1) DZ3235A1 (zh)
ES (1) ES2229020T3 (zh)
HK (1) HK1051860A1 (zh)
HU (1) HUP0202057A3 (zh)
IL (1) IL150431A0 (zh)
MX (1) MXPA02006225A (zh)
NO (1) NO20023112L (zh)
NZ (1) NZ519811A (zh)
PL (1) PL207995B1 (zh)
PT (1) PT1270576E (zh)
RU (1) RU2299210C2 (zh)
SI (1) SI1270576T1 (zh)
SK (1) SK5862002A3 (zh)
TR (1) TR200402391T4 (zh)
TW (1) TWI256393B (zh)
UA (1) UA76707C2 (zh)
ZA (1) ZA200204063B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
HUE031058T2 (en) * 2004-03-29 2017-06-28 Servier Lab A method of producing a solid pharmaceutical composition
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
CN102875550B (zh) * 2011-07-12 2016-01-06 常州合全药业有限公司 1,3,7-三取代-3,7-二氮杂双环[3,3,1]壬烷衍生物及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658558A1 (de) 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4742217A (en) * 1986-06-02 1988-05-03 Honeywell Inc. Projection alignment and focusing aid
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4402931A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4402933A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
PT1270576E (pt) 2004-11-30
CZ20021856A3 (cs) 2003-02-12
DZ3235A1 (fr) 2005-04-20
CA2391915A1 (en) 2002-12-28
EP1270576B1 (de) 2004-09-15
DK1270576T3 (da) 2004-10-11
CZ296878B6 (cs) 2006-07-12
DE50200996D1 (de) 2004-10-21
ZA200204063B (en) 2003-01-23
JP4223237B2 (ja) 2009-02-12
HUP0202057A2 (hu) 2003-01-28
CA2391915C (en) 2010-08-24
EP1270576A3 (de) 2003-03-12
BR0202419A (pt) 2003-04-29
NZ519811A (en) 2004-03-26
US6602880B2 (en) 2003-08-05
DE10131217A1 (de) 2003-01-09
CN1394860A (zh) 2003-02-05
ATE276254T1 (de) 2004-10-15
SI1270576T1 (en) 2005-02-28
US20030109541A1 (en) 2003-06-12
PL354774A1 (en) 2002-12-30
CN1303082C (zh) 2007-03-07
EP1270576A2 (de) 2003-01-02
ES2229020T3 (es) 2005-04-16
NO20023112D0 (no) 2002-06-27
TR200402391T4 (tr) 2004-12-21
IL150431A0 (en) 2002-12-01
RU2299210C2 (ru) 2007-05-20
AU5064402A (en) 2003-01-02
NO20023112L (no) 2002-12-30
AU781333B2 (en) 2005-05-19
KR20030002304A (ko) 2003-01-08
HUP0202057A3 (en) 2003-05-28
UA76707C2 (uk) 2006-09-15
SK5862002A3 (en) 2003-01-09
HU0202057D0 (zh) 2002-09-28
JP2003026677A (ja) 2003-01-29
HK1051860A1 (en) 2003-08-22
AR033772A1 (es) 2004-01-07
RU2002117066A (ru) 2004-02-20
PL207995B1 (pl) 2011-02-28
MXPA02006225A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
EP1207155A4 (en) DRUG COMPOSITIONS HAVING AGONIST THROMBOPOIETINE ACTIVITY
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
GB0007405D0 (en) Compounds
MY127066A (en) Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors.
MY132073A (en) Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
BG106346A (en) 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO-[3,4-i]PURIN-5-ONE DERIVATIVES
PL320059A1 (en) Derivatives of 1,2,3,4-tetrahydroquinoxalinodione
ZA200603538B (en) P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
ES8802153A1 (es) Procedimiento para preparar derivados de isoxazol y furano.
CO5271675A1 (es) Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
BG105728A (en) USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
GR3025207T3 (en) 2-Formylpyridine thiosemicarbazone derivatives, their preparation and their use as antitumor agents
TWI256393B (en) 3-Phenyl-3,7-diazabicyclo [3,3,1] nonane compounds and process for their preparation and medicaments containing these compounds
IL110831A0 (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
PL285752A1 (en) Method for manufacturing new indenoindols and a pharmaceutical composition
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
GB9125970D0 (en) New compounds
MXPA04003741A (es) Derivados novedosos de hidroxialquil indolocarbazol, metodo de preparacion y composiciones farmaceuticas que los contienen.
HUT64345A (en) Methods for producing amino-alkyl-pyrrolidinyl-thio-carbapeneme derivatives and pharmaceutical preparatives containing them as active agent
ATE364382T1 (de) Hemmer der aggregation von polyq
HK1059774A1 (en) Pyrrolo Ä2,1-BÜ Ä1,3Übenzothiazepines and their use for the preparation of medicaments with antipsychotic activity

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees